DOSSIER · 13F-HR · Q4 2025

BVF INC/IL

$3.0B in tracked AUM across 41 positions as of Q4 2025.

BI
CIK 0001056807 · last filed Dec 31, 2025
Total AUM
$3.0B
as of Q4 2025
Holdings
41
+41 QoQ
positions
Whale Score
65
65
tracked
Activity
41
+41 new, −0 sold
changes this Q
AI Analysis · Q4 2025

BVF INC/IL filed its latest 13F-HR for Q4 2025. 41 position changes this quarter — 41 new, 0 exited, 0 added, 0 trimmed.

Quarter at a glance — Q4 2025

41 material changes this filing.

NEW
KYMRKYMERA THERAPEUTICS INC
+5.5M sh
+$428M
14.4%
NEW
RVMDREVOLUTION MEDICINES INC
+3.4M sh
+$267M
9.0%
NEW
MLTXMOONLAKE IMMUNOTHERAPEUTICS
+19.8M sh
+$260M
8.8%
NEW
GPCRSTRUCTURE THERAPEUTICS INC
+3.5M sh
+$242M
8.1%
NEW
OLMAOLEMA PHARMACEUTICALS INC
+5.3M sh
+$132M
4.5%
NEW
MIRMMIRUM PHARMACEUTICALS INC
+1.5M sh
+$118M
4.0%
NEW
G3855L106GH RESEARCH PLC
+8.8M sh
+$112M
3.8%

Top 10 holdings

By portfolio weight as of Q4 2025. Source: SEC EDGAR 13F-HR filings.

#HoldingValueSharesWeight
01
KYMR
KYMERA THERAPEUTICS INC
$428M5.5M14.4%
02
RVMD
REVOLUTION MEDICINES INC
$267M3.4M9.0%
03
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
$260M19.8M8.8%
04
GPCR
STRUCTURE THERAPEUTICS INC
$242M3.5M8.1%
05
OLMA
OLEMA PHARMACEUTICALS INC
$132M5.3M4.5%
06
MIRM
MIRUM PHARMACEUTICALS INC
$118M1.5M4.0%
07
G3855L106
GH RESEARCH PLC
$112M8.8M3.8%
08
XNCR
XENCOR INC
$109M7.1M3.7%
09
ZYME
ZYMEWORKS INC
$104M3.9M3.5%
10
PVLA
PALVELLA THERAPEUTICS INC NE
$92M879K3.1%

Filing history

2025Q4Dec 31
$3.0B▲ 115.6%
41 positionsView →
2025Q3Sep 30
$1.4B▼ 50.8%
34 positionsLocked
2025Q2Jun 30
$2.8B▲ 52.7%
44 positionsLocked
2025Q1Mar 31
$1.8B▼ 37.9%
38 positionsLocked
2024Q4Dec 31
$3.0B▼ 13.7%
53 positionsLocked
2024Q3Sep 30
$3.4B▼ 4.2%
55 positionsLocked
2024Q2Jun 30
$3.6B▼ 1.9%
60 positionsLocked
2024Q1Mar 31
$3.6B▼ 9.0%
62 positionsLocked
2023Q4Dec 31
$4.0B▲ 7.7%
70 positionsLocked
2023Q3Sep 30
$3.7B▲ 3.4%
69 positionsLocked
2023Q2Jun 30
$3.6B▲ 31.2%
67 positionsLocked
2023Q1Mar 31
$2.7B▲ 15.5%
72 positionsLocked
Showing 12 of 78